CLEC11A and Hepatitis: In summary, the data from MeD-seq confirmed the results of qMSP that non-cirrhotic HCC had the highest methylation levels of HOXA1, CLEC11A, and TSPYL5 compared to hepatitis, benign lesions, and cirrhosis.